1 Introduction to Research & Analysis Reports 1.1 Cytomegalovirus Infection Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 China Cytomegalovirus Infection Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 China Cytomegalovirus Infection Overall Market Size 2.1 China Cytomegalovirus Infection Market Size: 2021 VS 2027 2.2 China Cytomegalovirus Infection Revenue, Prospects & Forecasts: 2016-2027 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Cytomegalovirus Infection Players in China Market 3.2 Top China Cytomegalovirus Infection Companies Ranked by Revenue 3.3 China Cytomegalovirus Infection Revenue by Companies 3.4 Top 3 and Top 5 Cytomegalovirus Infection Companies in China Market, by Revenue in 2020 3.5 Companies Cytomegalovirus Infection Product Type 3.6 Tier 1, Tier 2 and Tier 3 Cytomegalovirus Infection Players in China Market 3.6.1 List of Tier 1 Cytomegalovirus Infection Companies in China 3.6.2 List of Tier 2 and Tier 3 Cytomegalovirus Infection Companies in China 4 Sights by Type 4.1 Overview 4.1.1 By Type - China Cytomegalovirus Infection Market Size Markets, 2021 & 2027 4.1.2 Cidofovir 4.1.3 Foscarnet 4.1.4 Valganciclovir 4.1.5 Ganciclovir 4.2 By Type - China Cytomegalovirus Infection Revenue & Forecasts 4.2.1 By Type - China Cytomegalovirus Infection Revenue, 2016-2021 4.2.2 By Type - China Cytomegalovirus Infection Revenue, 2022-2027 4.2.3 By Type - China Cytomegalovirus Infection Revenue Market Share, 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - China Cytomegalovirus Infection Market Size, 2021 & 2027 5.1.2 Hospitals 5.1.3 Retail Pharmacies 5.1.4 Online Pharmacies 5.2 By Application - China Cytomegalovirus Infection Revenue & Forecasts 5.2.1 By Application - China Cytomegalovirus Infection Revenue, 2016-2021 5.2.2 By Application - China Cytomegalovirus Infection Revenue, 2022-2027 5.2.3 By Application - China Cytomegalovirus Infection Revenue Market Share, 2016-2027 6 Cytomegalovirus Infection Companies Profiles 6.1 Roche 6.1.1 Roche Company Details 6.1.2 Roche Business Overview 6.1.3 Roche Cytomegalovirus Infection Introduction 6.1.4 Roche Cytomegalovirus Infection Revenue in China Market (2016-2021) 6.1.5 Roche Recent Developments 6.2 GlaxoSmithKline 6.2.1 GlaxoSmithKline Company Details 6.2.2 GlaxoSmithKline Business Overview 6.2.3 GlaxoSmithKline Cytomegalovirus Infection Introduction 6.2.4 GlaxoSmithKline Cytomegalovirus Infection Revenue in China Market (2016-2021) 6.2.5 GlaxoSmithKline Recent Developments 6.3 Vical 6.3.1 Vical Company Details 6.3.2 Vical Business Overview 6.3.3 Vical Cytomegalovirus Infection Introduction 6.3.4 Vical Cytomegalovirus Infection Revenue in China Market (2016-2021) 6.3.5 Vical Recent Developments 6.4 AiCuris Anti-Infective Cures 6.4.1 AiCuris Anti-Infective Cures Company Details 6.4.2 AiCuris Anti-Infective Cures Business Overview 6.4.3 AiCuris Anti-Infective Cures Cytomegalovirus Infection Introduction 6.4.4 AiCuris Anti-Infective Cures Cytomegalovirus Infection Revenue in China Market (2016-2021) 6.4.5 AiCuris Anti-Infective Cures Recent Developments 6.5 ViroPharma 6.5.1 ViroPharma Company Details 6.5.2 ViroPharma Business Overview 6.5.3 ViroPharma Cytomegalovirus Infection Introduction 6.5.4 ViroPharma Cytomegalovirus Infection Revenue in China Market (2016-2021) 6.5.5 ViroPharma Recent Developments 6.6 Chimerix 6.6.1 Chimerix Company Details 6.6.2 Chimerix Business Overview 6.6.3 Chimerix Cytomegalovirus Infection Introduction 6.6.4 Chimerix Cytomegalovirus Infection Revenue in China Market (2016-2021) 6.6.5 Chimerix Recent Developments 7 Conclusion 8 Appendix 8.1 Note 8.2 Examples of Clients 8.3 Author Details 8.4 Disclaimer

List of Tables Table 1. Cytomegalovirus Infection Market Opportunities & Trends in China Market Table 2. Cytomegalovirus Infection Market Drivers in China Market Table 3. Cytomegalovirus Infection Market Restraints in China Market Table 4. Key Players of Cytomegalovirus Infection in China Market Table 5. Top Cytomegalovirus Infection Players in China Market, Ranking by Revenue (2019) Table 6. China Cytomegalovirus Infection Revenue by Companies, (US$, Mn), 2016-2021 Table 7. China Cytomegalovirus Infection Revenue Share by Companies, 2016-2021 Table 8. Companies Cytomegalovirus Infection Product Type Table 9. List of Tier 1 Cytomegalovirus Infection Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Cytomegalovirus Infection Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type – China Cytomegalovirus Infection Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - China Cytomegalovirus Infection Revenue (US$, Mn), 2016-2021 Table 13. By Type - China Cytomegalovirus Infection Revenue (US$, Mn), 2022-2027 Table 14. By Application – China Cytomegalovirus Infection Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - China Cytomegalovirus Infection Revenue (US$, Mn), 2016-2021 Table 16. By Application - China Cytomegalovirus Infection Revenue (US$, Mn), 2022-2027 Table 17. Roche Company Details Table 18. Roche Business Overview Table 19. Roche Cytomegalovirus Infection Product Table 20. Roche Cytomegalovirus Infection Revenue in China Market (2016-2021) & (US$ Million) Table 21. Roche Recent Developments Table 22. GlaxoSmithKline Company Details Table 23. GlaxoSmithKline Business Overview Table 24. GlaxoSmithKline Cytomegalovirus Infection Product Table 25. GlaxoSmithKline Cytomegalovirus Infection Revenue in China Market (2016-2021) & (US$ Million) Table 26. GlaxoSmithKline Recent Developments Table 27. Vical Company Details Table 28. Vical Business Overview Table 29. Vical Cytomegalovirus Infection Product Table 30. Vical Cytomegalovirus Infection Revenue in China Market (2016-2021) & (US$ Million) Table 31. Vical Recent Developments Table 32. AiCuris Anti-Infective Cures Company Details Table 33. AiCuris Anti-Infective Cures Business Overview Table 34. AiCuris Anti-Infective Cures Cytomegalovirus Infection Product Table 35. AiCuris Anti-Infective Cures Cytomegalovirus Infection Revenue in China Market (2016-2021) & (US$ Million) Table 36. AiCuris Anti-Infective Cures Recent Developments Table 37. ViroPharma Company Details Table 38. ViroPharma Business Overview Table 39. ViroPharma Cytomegalovirus Infection Product Table 40. ViroPharma Cytomegalovirus Infection Revenue in China Market (2016-2021) & (US$ Million) Table 41. ViroPharma Recent Developments Table 42. Chimerix Company Details Table 43. Chimerix Business Overview Table 44. Chimerix Cytomegalovirus Infection Product Table 45. Chimerix Cytomegalovirus Infection Revenue in China Market (2016-2021) & (US$ Million) Table 46. Chimerix Recent Developments List of Figures Figure 1. Cytomegalovirus Infection Segment by Type Figure 2. Cytomegalovirus Infection Segment by Application Figure 3. China Cytomegalovirus Infection Market Overview: 2020 Figure 4. China Cytomegalovirus Infection Market Size: 2021 VS 2027 (US$, Mn) Figure 5. China Cytomegalovirus Infection Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Cytomegalovirus Infection Revenue in 2020 Figure 7. By Type - China Cytomegalovirus Infection Revenue Market Share, 2016-2027 Figure 8. By Application - China Cytomegalovirus Infection Revenue Market Share, 2016-2027 Figure 9. Roche Cytomegalovirus Infection Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. GlaxoSmithKline Cytomegalovirus Infection Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Vical Cytomegalovirus Infection Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. AiCuris Anti-Infective Cures Cytomegalovirus Infection Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. ViroPharma Cytomegalovirus Infection Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Chimerix Cytomegalovirus Infection Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Roche GlaxoSmithKline Vical AiCuris Anti-Infective Cures ViroPharma Chimerix